# UK Registry for Baroreflex Activation Therapy

> **NCT03730519** · NA · TERMINATED · sponsor: **Queen Mary University of London** · enrollment: 6 (actual)

## Conditions studied

- Baroreflex Failure Syndrome
- Hypertension, Resistant to Conventional Therapy

## Interventions

- **DEVICE:** Baroreflex Activation Therapy with Barostim Neo

## Key facts

- **NCT ID:** NCT03730519
- **Lead sponsor:** Queen Mary University of London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-11-01
- **Primary completion:** 2021-11-01
- **Final completion:** 2021-11-01
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Due to the pandemic
- **Last updated:** 2023-06-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03730519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03730519, "UK Registry for Baroreflex Activation Therapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03730519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*